Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Vial, Thierry
and
Descotes, Jacques
2000.
Vol. 23,
Issue. ,
p.
391.
Fried, Michael W.
2002.
Side effects of therapy of hepatitis C and their management.
Hepatology,
Vol. 36,
Issue. S1,
p.
S237.
Fried, Michael W.
2002.
Side effects of therapy of hepatitis C and their management.
Hepatology,
Vol. 36,
Issue. 5B,
p.
s237.
Kaygusuz, İrfan
Kaygusuz, Türkkan Öztürk
Öztürk, Ahmet
Kiliç, Süleyman Sιrrι
Karlidağ, Turgut
Keleş, Erol
and
Yalçin, Şinasi
2004.
Effects of interferon-α2b on hearing.
International Journal of Audiology,
Vol. 43,
Issue. 8,
p.
438.
Matthews, S.James
and
McCoy, Christopher
2004.
Peginterferon alfa-2a: A review of approved and investigational uses.
Clinical Therapeutics,
Vol. 26,
Issue. 7,
p.
991.
Mitchell L, Shiffman
2004.
Side effects of medical therapy for chronic hepatitis C.
Annals of Hepatology,
Vol. 3,
Issue. 1,
p.
5.
Formann, Elisabeth
Stauber, Rudolf
Denk, Doris-Maria
Jessner, Wolfgang
Zollner, Gernot
Munda-Steindl, Petra
Gangl, Alfred
and
Ferenci, Peter
2004.
Sudden Hearing Loss in Patients with Chronic Hepatitis C Treated with Pegylated Interferon/Ribavirin.
The American Journal of Gastroenterology,
Vol. 99,
Issue. 5,
p.
873.
Sachar, Sutha
and
Polio, John
2004.
PEGYLATED-INTERFERON INDUCED OTOTOXICITY AS A SIDE EFFECT OF HEPATITIS C TREATMENT.
American Journal of Gastroenterology,
Vol. 99,
Issue. ,
p.
S96.
Wong, Victor K
2005.
Acute sensorineural hearing loss associated with peginterferon and ribavirin combination therapy during hepatitis C treatment: Outcome after resumption of therapy.
World Journal of Gastroenterology,
Vol. 11,
Issue. 34,
p.
5392.
Lazarini, Paulo Roberto
and
Camargo, Ana Cristina Kfouri
2006.
Surdez súbita idiopática: aspectos etiológicos e fisiopatogênicos.
Revista Brasileira de Otorrinolaringologia,
Vol. 72,
Issue. 4,
p.
554.
Pompili, M.
Pizzolante, F.
Larocca, L.M.
Covino, M.
Rapaccini, G.L.
and
Gasbarrini, G.
2006.
Ischaemic jejunal vasculitis during treatment with pegylated interferon-alpha 2b and ribavirin for hepatitis C virus related cirrhosis.
Digestive and Liver Disease,
Vol. 38,
Issue. 5,
p.
352.
2006.
Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions.
p.
1793.
Akimov, Sergey
and
Adeyemi, Oluwatoyin M
2006.
Peginterferon-α
2a
in the Treatment of Chronic Hepatitis C
.
Future Virology,
Vol. 1,
Issue. 6,
p.
689.
Lazarini, Paulo Roberto
and
Camargo, Ana Cristina Kfouri
2006.
Idiopathic sudden sensorineural hearing loss: etiopathogenic aspects.
Brazilian Journal of Otorhinolaryngology,
Vol. 72,
Issue. 4,
p.
554.
Block, F.
2006.
Medikamentös induzierte neurologische und psychiatrische Störungen.
p.
289.
Piekarska, Anna
Jozefowicz-Korczynska, Magdalena
Wojcik, Kamila
and
Berkan, Ewa
2007.
Sudden hearing loss in chronic hepatitis C patient suffering from Turner syndrome, treated with pegylated interferon and ribavirin.
International Journal of Audiology,
Vol. 46,
Issue. 7,
p.
345.
Kartal, Elif Doyuk
Alpat, Saygin Nayman
Ozgunes, Ilhan
and
Usluer, Gaye
2007.
Adverse effects of high-dose interferon-α-2a treatment for chronic hepatitis B.
Advances in Therapy,
Vol. 24,
Issue. 5,
p.
963.
Shin, Min Ki
Kim, Tae Hyo
Ju, Kang
Ha, Chang Yoon
Min, Hyun Ju
Jung, Woon Tae
and
Lee, Ok Jae
2009.
A case of sudden-onset hearing loss in a patient treated with peginterferon α-2b and ribavirin for chronic hepatitis C.
The Korean Journal of Hepatology,
Vol. 15,
Issue. 3,
p.
370.
Stübgen, Joerg-Patrick
2009.
Interferon alpha and neuromuscular disorders.
Journal of Neuroimmunology,
Vol. 207,
Issue. 1-2,
p.
3.
Kitada, Takuya
Narimatsu, Takashi
and
Yamaguchi, Seiko
2009.
Sudden hearing loss in a patient with chronic hepatitis C treated with pegylated interferon α2a and ribavirin.
Kanzo,
Vol. 50,
Issue. 7,
p.
371.